A reappraisal of ICU and long-term outcome of allogeneic hematopoietic stem cell transplantation patients and reassessment of prognosis factors: results of a 5-year cohort study (2009–2013)

Changes in intensive care for allogeneic hematopoietic stem cell transplant recipients

(2015) E Lengliné et al.   BONE MARROW TRANSPLANTATION

Risk factors for ICU admission and ICU survival after allogeneic hematopoietic SCT

(2013) R Benz et al.   BONE MARROW TRANSPLANTATION

Improved intensive care unit survival for critically ill allogeneic haematopoietic stem cell transplant recipients following reduced intensity conditioning

(2013) William M. Townsend et al.   BRITISH JOURNAL OF HAEMATOLOGY

Quantitative and qualitative differences in use and trends of hematopoietic stem cell transplantation: a Global Observational Study

(2013) A. Gratwohl et al.   HAEMATOLOGICA

Comparison of Pulmonary Complications after Nonmyeloablative and Conventional Allogeneic Hematopoietic Cell Transplant

(2012) Khalil J. Diab et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

The EBMT activity survey: 1990–2010

(2012) J R Passweg et al.   BONE MARROW TRANSPLANTATION

Impact of organ dysfunction on mortality in ICU patients with hematologic malignancies

(2010) Dominique M. Vandijck et al.   INTENSIVE CARE MEDICINE

Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation

(2010) Ted A. Gooley et al.   NEW ENGLAND JOURNAL OF MEDICINE

The sepsis-related Organ Failure Assessment (SOFA) score is predictive for survival of patients admitted to the intensive care unit following allogeneic blood stem cell transplantation

(2008) Frank Neumann et al.   ANNALS OF HEMATOLOGY